The T1D Exchange Registry
{ "The T1D Exchange Registry for Type 1 Diabetes", "The T1D Exchange Registry is an ongoing research study for people with type 1 diabetes and their families. This study doesn't test a new medicine; instead, it gathers information over time to better understand type 1 diabetes. You would share your health information through annual surveys. This helps researchers learn more about living with type 1 diabetes. To join, you need to have a diagnosis of type 1 diabetes, live in the United States, and be able to read and understand English. If you are under 18, a parent or guardian needs to give permission. The goal is to collect information for 10 years to create a large dataset for future research.", "design": "This is an observational study, meaning it collects information without testing a specific intervention. It aims to enroll 50,000 participants.", "commitments": "You will read and sign an online consent form, complete an initial survey, and update your information annually. You may also choose to participate in additional research opportunities.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for 10 years to gather longitudinal data.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The T1D Exchange Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Gather longitudinal data from individuals living with type 1 diabetes.10 years
Gather longitudinal data on disease, health status, and patient-reported outcomes of individuals living with type 1 diabetes. This will be achieved by presenting participants with annual questionnaires, tracking any changes in their responses over time.